NCT07244718Completed
Investigation of The Effect of Progressive Muscle Relaxation Technique in Sedentary Obese Women
Effects of Music-Assisted Progressive Muscle Relaxation on Sleep Quality, Fatigue, Emotional Symptoms, and Quality of Life in Sedentary Obese Women
Source: ClinicalTrials.gov · Last updated 9 Dec 2025
Brief summary (registry, in English)
Obesity is a major public health problem that reduces quality of life and increases the risk of many chronic diseases. Its global prevalence continues to rise, and it is estimated that approximately 18 percent of men and 21 percent of women will be affected by the year 2025. The development and progression of obesity are influenced by individual characteristics such as age, lifestyle, and gender. Women experience hormonally driven changes in body fat across different life stages, including puberty, reproductive years, and the postpartum period, which place them at higher metabolic risk. Progressive muscle relaxation, particularly when combined with music, has been shown to reduce sleep problems, emotional disturbances, fatigue, and limitations in quality of life across different clinical populations. However, the effectiveness of music-assisted progressive muscle relaxation in sedentary obese women has not been clearly demonstrated. This study investigates whether a six-week, home-based music-assisted progressive muscle relaxation program can improve sleep quality, emotional well-being, fatigue, and health-related quality of life in sedentary obese women. The intervention can be performed independently in the participants' own living environment, which supports sustainability and enhances self-management. Demonstrating the effectiveness of this method may offer healthcare professionals a low-cost, accessible, non-pharmacological treatment option to improve both physical and emotional well-being in this high-risk population.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 20 (actual)
- First submitted
- 17 Nov 2025
- Start date
- 1 Feb 2024
- Primary completion date
- 31 Jan 2025
- Lead sponsor
- Pamukkale University
- Diseases
- Obesity
- NCT number
- NCT07244718
What you commit to
- Study type: Interventional
- Participants enrolled: 20
- From 1 Feb 2024 to the primary completion date, 31 Jan 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Use of weight-loss medications or sedative-hypnotic drugs
Other illness
- Cognitive impairment affecting communication
- Hearing impairment
- Criteria for Withdrawal:
- Development of a condition preventing continuation of participation
- Failure to attend sessions regularly (missing more than two sessions per week)
Other
- Pregnancy, postpartum period, or lactation
- Not having a regular menstruation cycle
- Voluntary withdrawal from the study
- Incomplete final assessments
Who the study is looking for
- Female participants aged 18-50 years
- Classified as sedentary according to the International Physical Activity Questionnaire-Short Form (IPAQ-SF)
- Obese, defined as BMI ≥ 30 kg/m²
- Ability to understand written and spoken Turkish
- Ability to comprehend study instructions
- Active use of WhatsApp or Telegram to receive intervention materials
Age in the registry: 18 years to 50 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Pamukkale University Coordinator of this site? Confirm its status | Denizli | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.